PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,355,296 | -46.2% | 131,200 | -31.7% | 0.02% | -46.7% |
| Q2 2023 | $2,519,388 | -70.7% | 192,173 | -75.0% | 0.03% | -74.4% |
| Q1 2023 | $8,609,561 | +33.4% | 770,086 | +0.6% | 0.12% | +36.0% |
| Q4 2022 | $6,455,677 | -29.4% | 765,798 | +39.6% | 0.09% | -32.8% |
| Q3 2022 | $9,138,000 | +43.8% | 548,512 | +27.1% | 0.13% | +30.6% |
| Q2 2022 | $6,354,000 | -43.9% | 431,632 | -5.5% | 0.10% | -46.7% |
| Q1 2022 | $11,330,000 | -2.3% | 456,655 | +26.3% | 0.18% | +10.8% |
| Q4 2021 | $11,597,000 | -4.2% | 361,607 | +7.5% | 0.17% | -16.2% |
| Q3 2021 | $12,101,000 | -18.4% | 336,313 | +0.0% | 0.20% | -28.5% |
| Q2 2021 | $14,836,000 | +153.2% | 336,273 | +162.5% | 0.28% | +113.1% |
| Q1 2021 | $5,859,000 | -33.7% | 128,092 | +0.1% | 0.13% | -44.4% |
| Q4 2020 | $8,833,000 | – | 127,976 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $10,278,050 | 5.54% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $621,907 | 2.98% |
| PURA VIDA INVESTMENTS, LLC | 726,298 | $7,502,658 | 1.42% |
| CFM WEALTH PARTNERS LLC | 264,039 | $2,727,523 | 0.71% |
| BRAIDWELL LP | 988,559 | $10,211,814 | 0.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,017,958 | $10,515,506 | 0.23% |
| Rock Springs Capital Management LP | 652,400 | $6,739,292 | 0.18% |
| Point72 Asset Management, L.P. | 2,929,903 | $30,265,898 | 0.09% |
| ALGERT GLOBAL LLC | 117,327 | $1,212 | 0.06% |
| Campbell & CO Investment Adviser LLC | 45,380 | $468,775 | 0.06% |